Clinical trial
Clinical Trial to Evaluate the Safety and Efficacy of Levosulpiride to Improve Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.
NCT03161652 is registered in ClinicalTrials.gov with Carmen Clapp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Evaluate the Safety and Efficacy of Levosulpiride to Improve Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.
- Lead sponsor
- Carmen Clapp
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 24, 2017
- Completion date
- June 30, 2027
- Enrollment
- 120 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema, diabetic retinopathy